Palisade Bio (PALI)
(Delayed Data from NSDQ)
$3.41 USD
-0.08 (-2.16%)
Updated Oct 11, 2024 03:59 PM ET
After-Market: $3.40 -0.01 (-0.15%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth C Momentum D VGM
Palisade Bio, Inc. (PALI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$33.75 | $45.00 | $22.50 | 869.83% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Palisade Bio, Inc. comes to $33.75. The forecasts range from a low of $22.50 to a high of $45.00. The average price target represents an increase of 869.83% from the last closing price of $3.48.
Analyst Price Targets (2 )
Broker Rating
Palisade Bio, Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on two recommendations.
Of the two recommendations deriving the current ABR, two are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/16/2024 | Maxim Group | Naz Rahman | Strong Buy | Strong Buy |
3/15/2024 | LadenburgThalmann | Aydin Huseynov | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 2 |
Average Target Price | $33.75 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 85 of 252 |
Current Quarter EPS Est: | NA |
PALI FAQs
Palisade Bio, Inc. (PALI) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 2 brokerage firms.
The average price target for Palisade Bio, Inc. (PALI) is $33.75. The current on short-term price targets is based on 1 reports.
The forecasts for Palisade Bio, Inc. (PALI) range from a low of $22.5 to a high of $45. The average price target represents a increase of $889.74 from the last closing price of $3.41.
The current UPSIDE for Palisade Bio, Inc. (PALI) is 889.74%
Based on short-term price targets offered by two analysts, the average price target for Palisade Bio, Inc. comes to $33.75. The forecasts range from a low of $22.50 to a high of $45.00. The average price target represents an increase of 869.83% from the last closing price of $3.48.